BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

ABR–Affinity BioReagents Inks New Distribution Agreements in Switzerland and Hungary


5/9/2008 11:02:54 AM

DENVER and GOLDEN, Colo., May 9 /PRNewswire/ -- ABR-Affinity BioReagents, a leading global antibody manufacturer, announced today the finalization of new distribution agreements with LuBioScience GmbH, headquartered in Lucerne, Switzerland and Bio-Kasztel Ltd., located in Budapest, Hungary, further expanding its already extensive network of distribution partners in Europe.

LubioScience has more than 30 years of expertise in handling marketing and sales of life science reagents in Switzerland and distributes a broad range of life science reagents for experimental use in laboratories. Similarly, Bio-Kasztel has long-term marketing and distribution experience and close ties with all of the top-level academic and research institutions in Hungary. According to Ken Wilczek, President of ABR-Affinity BioReagents, "Partnering with companies like LuBioScience and Bio-Kasztel enhances our presence in the growing European life science community, and we have a history of working closely with high caliber distribution partners such as these to really penetrate deep into foreign markets. These types of international distribution arrangements allow us the ability and flexibility to offer our quality guaranteed experimental research tools to foreign-based scientists who are active in the worldwide effort to combat disease and enhance the quality of life for everyone." With the recent launch of over 1,600 new products in the areas of Neuroscience, Cancer Biology, Immunology, Inflammation and Arthritis, Diabetes and Vision Research, ABR-Affinity BioReagents' portfolio of high quality antibodies continues to grow in breadth and depth of research reagents available worldwide.

About ABR-Affinity BioReagents

Founded in 1989 with world headquarters in Golden, Colorado, ABR-Affinity BioReagents is a world leader in the manufacture and distribution of monoclonal and polyclonal antibodies, kits, recombinant proteins, and custom antibody and peptide production services, known as Antibody on Demand.

With more than 36,000 antibodies focused in 43 research areas, ABR offers a unique value proposition in the life science industry -- research antibodies that are 100% quality guaranteed or your money back -- with no questions asked.

Utilizing a distribution network encompassing over 60 nations, ABR products are readily available in every research market on the globe. Products are available directly from ABR in the United States, as well as through an exclusive distribution partnership with Fisher Scientific, a division of Thermo Fisher Scientific.

Leslie Martin with ABR media relations at 1-800-527-4535.

CONTACT: Leslie Martin of ABR-Affinity BioReagents, 1-800-527-4535

Web site: http://www.bioreagents.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->